Tracie Oliver's Net Worth
$3.38 Million
Who is Tracie Oliver?
Tracie Oliver has an estimated net worth of $3.38 Million. This is based on reported shares in ARROWHEAD PHARMACEUTICALS, INC..
SEC CIK
Tracie Oliver's CIK is 0001935706
Past Insider Trading and Trends
2023 was Tracie Oliver's most active year for acquiring shares with 1 total transactions. Tracie Oliver's most active month to acquire stocks was the month of December. 2024 was Tracie Oliver's most active year for disposing of shares, totalling 2 transactions. Tracie Oliver's most active month to dispose stocks was the month of June. 2024 saw Tracie Oliver paying a total of $0.00 for 75,000 shares, this is the most they've acquired in one year. In 2023 Tracie Oliver cashed out on 8,925 shares for a total of $315,141.75, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Snapshot price: $22.22
Chief Commercial OfficerTracie Oliver owns 127,107 units of Common Stock which is worth $2,824,317.54. From 2022 to 2024 Tracie Oliver acquired a total of 75,500 shares in ARROWHEAD PHARMACEUTICALS, INC., Tracie also disposed a total of 18,393 shares of ARROWHEAD PHARMACEUTICALS, INC. equalling to $555,129.93.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.88% | -9.39K |
$25.28 | -$237,480.32 | 127.11K |
Scheduled
|
Jul 2
| ||
Form 4
| +121.68% | 74.93K |
$33.89 | -$2,507.86 | 136.5K |
Scheduled
|
Jan 4 - Jan 5
| ||
Form 4
| -12.66% | -8.93K |
$35.31 | -$315,141.75 | 61.58K |
Jul 3
| |||
Form 4
| +0.71% | 500 |
—
|
—
| 70.5K |
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |